Patents by Inventor Amy Stafford

Amy Stafford has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12167905
    Abstract: Methods and a system are provided for assessing postpartum hemorrhage risk and postpartum hemorrhage stages in a clinical setting. Generally, a clinician may indicate that the mass of several bloody items, indicated in type and quantity, is to be measured using a scale. The mass of bloody items is compared to the known unused dry mass of such items in order to accurately determine the quantitative blood loss (QBL) of a patient at the bedside. The cumulative QBL can be updated by weighing additional items. Based on the cumulative QBL, the patient's vital signs, and other factors, a corresponding hemorrhage stage is identified and communicated to the clinician. Recommendations specific to the hemorrhage stage are provided to a clinician. Some recommendations are selectable actions that trigger automatic placement of medical orders and notifications to relevant medical services, such as a blood bank or anesthesia.
    Type: Grant
    Filed: October 22, 2021
    Date of Patent: December 17, 2024
    Assignee: Cerner Innovation, Inc.
    Inventors: Patrizia Smouse Gomez, Jessica Alford, Krystal Cunningham, Ginger Querner, Justin Peterson, Yash Goyal, Hemin Merchant, Peng Li, Amy Stafford
  • Publication number: 20220039672
    Abstract: Methods and a system are provided for assessing postpartum hemorrhage risk and postpartum hemorrhage stages in a clinical setting. Generally, a clinician may indicate that the mass of several bloody items, indicated in type and quantity, is to be measured using a scale. The mass of bloody items is compared to the known unused dry mass of such items in order to accurately determine the quantitative blood loss (QBL) of a patient at the bedside. The cumulative QBL can be updated by weighing additional items. Based on the cumulative QBL, the patient's vital signs, and other factors, a corresponding hemorrhage stage is identified and communicated to the clinician. Recommendations specific to the hemorrhage stage are provided to a clinician. Some recommendations are selectable actions that trigger automatic placement of medical orders and notifications to relevant medical services, such as a blood bank or anesthesia.
    Type: Application
    Filed: October 22, 2021
    Publication date: February 10, 2022
    Inventors: Patrizia Smouse Gomez, Jessica Alford, Krystal Cunningham, Ginger Querner, Justin Peterson, Yash Goyal, Hemin Merchant, Peng Li, Amy Stafford
  • Patent number: 11185236
    Abstract: Methods and a system are provided for assessing postpartum hemorrhage risk and postpartum hemorrhage stages in a clinical setting. Generally, a clinician may indicate that the mass of several bloody items, indicated in type and quantity, is to be measured using a scale. The mass of bloody items is compared to the known unused dry mass of such items in order to accurately determine the quantitative blood loss (QBL) of a patient at the bedside. The cumulative QBL can be updated by weighing additional items. Based on the cumulative QBL, the patient's vital signs, and other factors, a corresponding hemorrhage stage is identified and communicated to the clinician. Recommendations specific to the hemorrhage stage are provided to a clinician. Some recommendations are selectable actions that trigger automatic placement of medical orders and notifications to relevant medical services, such as a blood bank or anesthesia.
    Type: Grant
    Filed: December 28, 2015
    Date of Patent: November 30, 2021
    Assignee: CERNER INNOVATION, INC.
    Inventors: Patrizia Smouse Gomez, Jessica Alford, Krystal Cunningham, Ginger Querner, Justin Peterson, Yash Goyal, Hemin Merchant, Peng Li, Amy Stafford
  • Publication number: 20170185739
    Abstract: Methods and a system are provided for assessing postpartum hemorrhage risk and postpartum hemorrhage stages in a clinical setting. Generally, a clinician may indicate that the mass of several bloody items, indicated in type and quantity, is to be measured using a scale. The mass of bloody items is compared to the known unused dry mass of such items in order to accurately determine the quantitative blood loss (QBL) of a patient at the bedside. The cumulative QBL can be updated by weighing additional items. Based on the cumulative QBL, the patient's vital signs, and other factors, a corresponding hemorrhage stage is identified and communicated to the clinician. Recommendations specific to the hemorrhage stage are provided to a clinician. Some recommendations are selectable actions that trigger automatic placement of medical orders and notifications to relevant medical services, such as a blood bank or anesthesia.
    Type: Application
    Filed: December 28, 2015
    Publication date: June 29, 2017
    Inventors: Patrizia Smouse Gomez, Jessica Alford, Krystal Cunningham, Ginger Querner, Justin Peterson, Yash Goyal, Hemin Merchant, Peng Li, Amy Stafford